Neural contribution to the effect of glucagon-like peptide-1-(7 - 36) amide on arterial blood pressure in rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 5 40-5, 1999, Pages

  Barragán, José Manuel ^a   Eng, John ^b   Rodríguez, Raquel ^a   Blázquez, Enrique ^c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cardiovascular parameters; Neural control; Vagal mediation

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032714917     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.5.e784     Document Type: Article

References (40)

1. Alvarez, E., I. Roncero, J. A. Chowen, B. Thorens, and E. Blázquez. Expression of the glucagon like peptide-1 receptor gene in rat brain. J. Neurochem. 66: 920-927, 1996.
2. Barragán, J. M., R. Rodríguez, and E. Blázquez. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7 - 36) amide in rats. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E459-E466, 1994.
3. Barragán, J. M., R. Rodríguez, J. Eng, and E. Blázquez. Interactions of exendin (9 - 39) with the effects of glucagon-like peptide-1-(7 - 36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul. Pept. 67: 63-68, 1996.
4. Bell, G. I., R. F. Santerre, and G. T. Mullenbach. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302: 716-718, 1983.
5. Benito, E., E. Blázquez, and M. A. Bosch. Glucagon-like peptide-1-(7 - 36) amide increases pulmonary surfactant secretion through a cyclic adenosine 3′,5′-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes. Endocrinology 139: 2363-2368, 1998.
6. Calvo, J. C., B. Yusta, F. Mora, and E. Blázquez. Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7 - 36) amide receptor in rat brain. J. Neurochem. 64: 299-306, 1995.
7. Campos, R. V., Y. C. Lee, and D. J. Drucker. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134: 2156-2164, 1994.
8. Cechetto, D. F. Central representation of visceral function. Federation Proc. 46: 17-23, 1987.
9. Drucker, D. J., P. Ehrlich, S. L. Asa, and P. Brubaker. Induction of intestinal proliferation by glucagon-like peptide-2. Proc. Natl. Acad. Sci. USA 84: 3434-3438, 1996.
10. Dunbar, J. C., E. Ergene, G. F. Anderson, and R. A. Barraco. Decreased cardiorespiratory effects of neuropeptide Y in the nucleus tractus solitarius in diabetes. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R865-R871, 1992.
11. Edwards, C. M. B., A. V. Edwards, and S. R. Bloom. Cardiovascular and pancreatic endocrine responses to glucagon-like peptide-1 (7 - 36) amide in the conscious calf. Exp. Physiol. 82: 709-716, 1997.
12. Edwards, C. M. B., J. F. Todd, M. A. Ghatei, and S. R. Bloom. Subcutaneous glucagon-like peptide-I (7 - 36) is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. Clin. Sci. (Colch.) 96: 719-724, 1998.
13. Ferguson, A. V. The area postrema: a cardiovascular control centre at the blood-brain interface? Can. J. Physiol. Pharmacol. 69: 1026-1034, 1991.
14. Göke, R., and J. M. Conlon. Receptors for glucagon-like peptide-1 (7 - 36) amide on rat insulinoma-derived cells. J. Endocrinol. 116: 357-362, 1988.
15. Göke, R., P. J. Larsen, J. D. Mikkelsen, and S. P. Sheikh. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7: 2294-2300, 1995.
16. Jin, S. L. C., V. K. M. Han, J. E. Simmons, A. C. Towle, J. M. Lander, and P. K. Lund. Distribution of glucagon-like peptide-1 (GLP-1), glucagon, and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neurol. 271: 519-532, 1988.
17. Kanse, S. M., B. Kreymann, M. A. Ghatei, and S. R. Bloom. Identification and characterization of glucagon-like peptide-1 (7-36) amide-binding sites in the rat brain and lung. FEBS Lett. 241: 209-212, 1988
18. Kreymann, B., M. A. Ghatei, P. Burnet, G. Williams, S. Kanse, A. R. Diani, and S. R. Bloom. Characterization of glucagon-like peptide-1 (7 - 36) amide in the hypothalamus. Brain Res. 502: 325-331, 1989.
19. Kreymann, B., G. Williams, M. A. Ghatei, and S. R. Bloom. Glucagon-like peptide I (7 - 36): a physiological incretin in man. Lancet 2: 1300-1304, 1987.
20. Mojsov, S., G. Heinrich, I. B. Wilson, M. Ravazzola, L. Orci, and J. F Habener. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 261: 11880-11889, 1986.
21. Mora, F, I. Expósito, B. Sanz, and E. Blázquez. Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36) amide in the basal ganglia of the conscious rat. Brain Res. Bull. 29: 359-361, 1992.
22. Navarro, M., F. Rodríguez de Fonseca, E. Alvarez, J. A. Chowen, J. A. Zueco, R. Gómez, J. Eng, and E. Blázquez. Colocalization of glucagon-like peptide-1 (GLP-1) receptor, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neurochem. 67: 1982-1991, 1996.
23. Orskov, C., A. Wettergren, S. D. S. Poulsen, and J. J. Holst. Is the effect of glucagon-like peptide-1 on gastric emptying centrally mediated (Abstract)? Diabetologia 8, Suppl. 1: A39, 1995.
24. Orskov, C., S. S. Poulsen, M. Moller, and J. J. Holst. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45: 832-835, 1996.
25. Parmley, W. W., G. Glick, and E. H. Sonnenblick. Cardiovascular effects of glucagon in man. N. Engl. J. Med. 279: 12-17, 1968.
26. Paxinos, G., and C. Watson. The Rat Brain in Stereotaxic Coordinates (2nd ed.). New York: Academic, 1986.
27. Raufman, J. P., L. Singh, and J. Eng. Truncated glucagon like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. J. Biol. Chem. 267: 21432-21437, 1992.
28. Richter, G., G. Göke, B. Göke, H. Schmidt, and R. Arnold. Characterization of glucagon-like peptide-I (7-36) amide receptors of rat lung membranes by covalent cross-linking. FEBS Lett. 280: 247-250, 1991.
29. Sainsbury, A., F. Rohner-Jeanrenaud, I. Cusin, K. E. Zakrzewska, P.A. Halban, R. C. Gaillard, and B. Jeanrenaud. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40: 1269-1277, 1997.
30. Shimizu, I., M. Hirota, C. Obhoshi, and K. Shima. Identification and characterization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 121: 1076-1082, 1987.
31. Smitherman, T. C., R. C. Osborn, and J. M. Atkins. Cardiac dose-response relationship for intravenously infused glucagon in normal intact dogs and men. Am. Heart J. 96: 363, 1978.
32. Tang-Christensen, M., P. J. Larsen, R. Göke, A. Fink-Jensen, D. S. Jessop, M. Moller, amd S. P. Sheikh. Central administration of GLP-1-(7 - 36) amide inhibits food and water intake in rats. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R848-R856, 1996.
33. Thorens, B. Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc. Natl. Acad. Sci. USA 89: 8641-8645, 1992.
34. Turton, M. D., D. O'Shea, I. Gunn, S. A. Beak, C. M. B. Edwards, K. Meeran, S. J. Choi, G. M. Taylor, M. M. Heath, P. D. Lambert, J. P. H. Wilding, D. M. Smith, M. A. Ghatei, J. Herbert, and S. R. Bloom. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1992.
35. Utthenthal, L. O., and E. Blázquez. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Lett. 262: 139-141, 1990.
36. Uttenthal, L. O., A. Toledano, and E. Blázquez. Autoradiographic localization of receptors for glucagon-like peptide-1 (7 - 36) amide in rat brain. Neuropeptides 21: 143-146, 1992.
37. Valverde, I, E. Mérida, E. Delgado, M. A. Trapote, and M. L. Villanueva-Peñacarrillo. Presence and characterization of glucagon-like peptide-1 (7 - 36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132: 75-79, 1993.
38. Wei, Y., and S. Mojsov. Tissue-specific expression of the human receptor for glucagon-like peptide I: brain, heart, and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 358: 219-224, 1995.
39. Wettergren, A., B. Schjoldager, P. E. Mortensen, J. Myhre, J. Christiansen, and J. J. Holst. Truncated GLP-1 (proglucagon 72-107 amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sci. 38: 665-673, 1993.
40. Whitcomb, D. C., and I. L. Taylor. A new twist in the brain-gut axis. Am. J. Med. Sci. 304: 334-338, 1992.